Centene Corp., US15133V1035

Centene Stock - Analyst consensus and valuation snapshot

22.06.2026 - 09:05:10 | ad-hoc-news.de

Centene stock sits between recent Medicaid redetermination headwinds and a still-solid earnings outlook. This Monday update summarizes where Wall Street stands on the managed-care group, including current consensus estimates and valuation metrics.

Centene Corp., US15133V1035
Centene Corp., US15133V1035

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 09:04 CET. Details in the imprint.

Centene Corp. (US15133V1035) remains a closely watched name in US managed care as investors weigh Medicaid redetermination impacts against its diversified government-backed health insurance portfolio. With no fresh corporate news this Monday, the focus turns to earnings expectations and the broader calendar.

Go deeper

All news and analysis on Centene stock

Background reports, price data and earlier earnings coverage on Centene are bundled in the dedicated topic section for this health insurer.

What analysts currently expect

Centene last updated investors with its first-quarter numbers in late April, giving the market a fresher base for 2025 estimates after a year of Medicaid eligibility reviews and membership churn.

Consensus data compiled by large financial portals shows Wall Street expecting low- to mid-single-digit revenue growth for Centene over the next 12 months, coupled with a continued focus on margin stability rather than aggressive top-line expansion.

Monday focus on the earnings calendar

Looking ahead, Centene is expected to report its next quarterly earnings around late July, in line with its usual reporting rhythm, though an exact date has not yet been formally fixed on its investor relations calendar.

For investors, that upcoming release is likely to center on updated guidance around Medicaid redeterminations, exchange plan membership trends and the performance of its Medicare Advantage book.

How the company makes money

Centene generates most of its revenue by providing government-sponsored health coverage, including Medicaid and Medicare plans, as well as Affordable Care Act marketplace products and specialty services such as behavioral health support.

Where the stock trades today

Centene stock trades on the New York Stock Exchange at $70.00 as of 06/22/2026, 09:04 CET.

Centene at a glance

  • Company: Centene Corp.
  • ISIN: US15133V1035
  • WKN: A0RBGN
  • Ticker: CNC
  • Venue: NYSE
  • Price (as of 06/22/2026, 09:04 CET): 70.00 USD
  • Market cap: 37,000,000,000 USD (as of 06/22/2026)
  • Sector / Industry: Health Care / Managed Health Care
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on Centene stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US15133V1035 | CENTENE CORP. | boerse | 69600984 | bgmi